Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 131

1.

Comparison of 18 FDG PET-CT and bone scintigraphy for detection of bone metastases in breast cancer patients. A meta-analysis.

Rong J, Wang S, Ding Q, Yun M, Zheng Z, Ye S.

Surg Oncol. 2013 Jun;22(2):86-91. doi: 10.1016/j.suronc.2013.01.002. Epub 2013 Feb 8. Review.

PMID:
23726506
2.

18FDG PET-CT for diagnosis of distant metastases in breast cancer patients. A meta-analysis.

Hong S, Li J, Wang S.

Surg Oncol. 2013 Jun;22(2):139-43. doi: 10.1016/j.suronc.2013.03.001. Epub 2013 Apr 5. Review.

PMID:
23566435
3.

Comparison of FDG-PET/CT and bone scintigraphy for detection of bone metastases in breast cancer.

Hahn S, Heusner T, Kümmel S, Köninger A, Nagarajah J, Müller S, Boy C, Forsting M, Bockisch A, Antoch G, Stahl A.

Acta Radiol. 2011 Nov 1;52(9):1009-14. doi: 10.1258/ar.2011.100507. Epub 2011 Oct 3.

PMID:
21969709
4.

Meta-analysis: accuracy of 18FDG PET-CT for distant metastasis staging in lung cancer patients.

Li J, Xu W, Kong F, Sun X, Zuo X.

Surg Oncol. 2013 Sep;22(3):151-5. doi: 10.1016/j.suronc.2013.04.001. Epub 2013 May 9. Review.

PMID:
23664848
5.

Comparison of FDG PET/CT and gadolinium-enhanced MRI for the detection of bone metastases in patients with cancer: a meta-analysis.

Duo J, Han X, Zhang L, Wang G, Ma Y, Yang Y.

Clin Nucl Med. 2013 May;38(5):343-8. doi: 10.1097/RLU.0b013e3182817af3.

PMID:
23531774
6.

18 FDG PET and PET-CT for the detection of bone metastases in patients with head and neck cancer. A meta-analysis.

Yi X, Fan M, Liu Y, Zhang H, Liu S.

J Med Imaging Radiat Oncol. 2013 Dec;57(6):674-9. doi: 10.1111/1754-9485.12077. Epub 2013 Jun 24.

PMID:
24283555
7.

Meta-analysis: comparison of F-18 Fluorodeoxyglucose-positron emission tomography and bone scintigraphy in the detection of bone metastases in patients with breast cancer.

Shie P, Cardarelli R, Brandon D, Erdman W, Abdulrahim N.

Clin Nucl Med. 2008 Feb;33(2):97-101. doi: 10.1097/RLU.0b013e31815f23b7. Erratum in: Clin Nucl Med. 2008 May;33(5):329.

PMID:
18209527
8.

A meta-analysis of ¹⁸FDG-PET-CT, ¹⁸FDG-PET, MRI and bone scintigraphy for diagnosis of bone metastases in patients with lung cancer.

Qu X, Huang X, Yan W, Wu L, Dai K.

Eur J Radiol. 2012 May;81(5):1007-15. doi: 10.1016/j.ejrad.2011.01.126. Epub 2011 Feb 26. Review.

PMID:
21354739
9.
10.

Meta-analysis: comparison of F-18 fluorodeoxyglucose-positron emission tomography and bone scintigraphy in the detection of bone metastasis in patients with lung cancer.

Chang MC, Chen JH, Liang JA, Lin CC, Yang KT, Cheng KY, Yeh JJ, Kao CH.

Acad Radiol. 2012 Mar;19(3):349-57. doi: 10.1016/j.acra.2011.10.018. Epub 2011 Dec 14. Review.

PMID:
22173321
11.

Diagnostic value of fluorine 18 fluorodeoxyglucose positron emission tomography/computed tomography for the detection of metastases in non-small-cell lung cancer patients.

Wu Y, Li P, Zhang H, Shi Y, Wu H, Zhang J, Qian Y, Li C, Yang J.

Int J Cancer. 2013 Jan 15;132(2):E37-47. doi: 10.1002/ijc.27779. Epub 2012 Sep 1.

12.

Fluorine-18 deoxyglucose positron emission tomography, magnetic resonance imaging and bone scintigraphy for the diagnosis of bone metastases in patients with lung cancer: which one is the best?--a meta-analysis.

Liu T, Xu JY, Xu W, Bai YR, Yan WL, Yang HL.

Clin Oncol (R Coll Radiol). 2011 Jun;23(5):350-8. doi: 10.1016/j.clon.2010.10.002. Epub 2010 Nov 20.

PMID:
21094027
13.

18F-FDG PET/CT and PET for evaluation of pathological response to neoadjuvant chemotherapy in breast cancer: a meta-analysis.

Cheng X, Li Y, Liu B, Xu Z, Bao L, Wang J.

Acta Radiol. 2012 Jul;53(6):615-27. doi: 10.1258/ar.2012.110603. Epub 2012 Jun 25.

PMID:
22734080
14.

Significance of hormone receptor status in comparison of 18F -FDG-PET/CT and 99mTc-MDP bone scintigraphy for evaluating bone metastases in patients with breast cancer: single center experience.

Teke F, Teke M, Inal A, Kaplan MA, Kucukoner M, Aksu R, Urakci Z, Tasdemir B, Isikdogan A.

Asian Pac J Cancer Prev. 2015;16(1):387-91.

15.

18 F-fluorodeoxyglucose positron emission tomography to evaluate recurrent gastric cancer: a systematic review and meta-analysis.

Wu LM, Hu JN, Hua J, Gu HY, Zhu J, Xu JR.

J Gastroenterol Hepatol. 2012 Mar;27(3):472-80. doi: 10.1111/j.1440-1746.2011.06919.x. Review.

PMID:
21916986
16.

Systematic review and meta-analysis on the diagnostic performance of FDG-PET/CT in detecting bone marrow involvement in newly diagnosed Hodgkin lymphoma: is bone marrow biopsy still necessary?

Adams HJ, Kwee TC, de Keizer B, Fijnheer R, de Klerk JM, Littooij AS, Nievelstein RA.

Ann Oncol. 2014 May;25(5):921-7. doi: 10.1093/annonc/mdt533. Epub 2013 Dec 18. Review.

PMID:
24351400
17.

Comparison of ¹⁸F-fluoride PET/CT, ¹⁸F-FDG PET/CT and bone scintigraphy (planar and SPECT) in detection of bone metastases of differentiated thyroid cancer: a pilot study.

Ota N, Kato K, Iwano S, Ito S, Abe S, Fujita N, Yamashiro K, Yamamoto S, Naganawa S.

Br J Radiol. 2014 Feb;87(1034):20130444.

18.

Comparison of the diagnostic value of FDG-PET/CT and axillary ultrasound for the detection of lymph node metastases in breast cancer patients.

Riegger C, Koeninger A, Hartung V, Otterbach F, Kimmig R, Forsting M, Bockisch A, Antoch G, Heusner TA.

Acta Radiol. 2012 Dec 1;53(10):1092-8. doi: 10.1258/ar.2012.110635. Epub 2012 Sep 22.

PMID:
23002144
19.

[18F]Fluorodeoxyglucose (FDG)-Positron Emission Tomography (PET)/Computed Tomography (CT) in Suspected Recurrent Breast Cancer: A Prospective Comparative Study of Dual-Time-Point FDG-PET/CT, Contrast-Enhanced CT, and Bone Scintigraphy.

Hildebrandt MG, Gerke O, Baun C, Falch K, Hansen JA, Farahani ZA, Petersen H, Larsen LB, Duvnjak S, Buskevica I, Bektas S, Søe K, Jylling AM, Ewertz M, Alavi A, Høilund-Carlsen PF.

J Clin Oncol. 2016 Jun 1;34(16):1889-97. doi: 10.1200/JCO.2015.63.5185. Epub 2016 Mar 21.

PMID:
27001573
20.

FDG PET/CT for the detection of bone marrow involvement in diffuse large B-cell lymphoma: systematic review and meta-analysis.

Adams HJ, Kwee TC, de Keizer B, Fijnheer R, de Klerk JM, Nievelstein RA.

Eur J Nucl Med Mol Imaging. 2014 Mar;41(3):565-74. doi: 10.1007/s00259-013-2623-4. Epub 2013 Nov 27. Review.

PMID:
24281821

Supplemental Content

Support Center